Cargando…
Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471582/ http://dx.doi.org/10.1192/j.eurpsy.2021.519 |
_version_ | 1784789111178002432 |
---|---|
author | Partera, J.Á. Alcalá Navas, A. Fontalba Morales, M. Company Guillena, S.L. Romero Higueras, T. Gutiérrez Cortés, F. Calera Forés, S. Vicent Rojas, L. Gutiérrez |
author_facet | Partera, J.Á. Alcalá Navas, A. Fontalba Morales, M. Company Guillena, S.L. Romero Higueras, T. Gutiérrez Cortés, F. Calera Forés, S. Vicent Rojas, L. Gutiérrez |
author_sort | Partera, J.Á. Alcalá |
collection | PubMed |
description | INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related to previous medicine. OBJECTIVES: To analyse the individual perception that the patient with Bipolar Disorder has regarding the positive and negative aspects of taking the recommended medication. METHODS: Descriptive and interpretative observational study under the qualitative paradigm of research, extracting the data through the completion of four focus groups with ten patients everyone. To complete the codification of the content of the participant’s discourses, we rely on the QRS NVivo 10 computer program. RESULTS: In the participant’s discourse concerning the main barriers to pharmacological treatment, for example “It’s because we live in a society and, because of that, we don’t go without medicine; if we didn’t live in society, we wouldn’t take medicine because we wouldn’t bother anyone”. Some examples of patient’s discourse, about perceived facilitators were: “I have to take medicine for my bipolar disorder, that’s it, I have a treatment, my illness has a name”. CONCLUSIONS: The main facilitators regarding the use of pharmacological treatment in Bipolar Disorder are the perceived need for treatment in the acute phase and the recognition of the illness, the shared clinical decision and the causal biological attribution in the chronic phase. About perceived barriers, social control is identified in both phases, adverse effects in the acute cases and the absence of effective treatment in the chronic state. |
format | Online Article Text |
id | pubmed-9471582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94715822022-09-29 Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients Partera, J.Á. Alcalá Navas, A. Fontalba Morales, M. Company Guillena, S.L. Romero Higueras, T. Gutiérrez Cortés, F. Calera Forés, S. Vicent Rojas, L. Gutiérrez Eur Psychiatry Abstract INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related to previous medicine. OBJECTIVES: To analyse the individual perception that the patient with Bipolar Disorder has regarding the positive and negative aspects of taking the recommended medication. METHODS: Descriptive and interpretative observational study under the qualitative paradigm of research, extracting the data through the completion of four focus groups with ten patients everyone. To complete the codification of the content of the participant’s discourses, we rely on the QRS NVivo 10 computer program. RESULTS: In the participant’s discourse concerning the main barriers to pharmacological treatment, for example “It’s because we live in a society and, because of that, we don’t go without medicine; if we didn’t live in society, we wouldn’t take medicine because we wouldn’t bother anyone”. Some examples of patient’s discourse, about perceived facilitators were: “I have to take medicine for my bipolar disorder, that’s it, I have a treatment, my illness has a name”. CONCLUSIONS: The main facilitators regarding the use of pharmacological treatment in Bipolar Disorder are the perceived need for treatment in the acute phase and the recognition of the illness, the shared clinical decision and the causal biological attribution in the chronic phase. About perceived barriers, social control is identified in both phases, adverse effects in the acute cases and the absence of effective treatment in the chronic state. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471582/ http://dx.doi.org/10.1192/j.eurpsy.2021.519 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Partera, J.Á. Alcalá Navas, A. Fontalba Morales, M. Company Guillena, S.L. Romero Higueras, T. Gutiérrez Cortés, F. Calera Forés, S. Vicent Rojas, L. Gutiérrez Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title | Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title_full | Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title_fullStr | Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title_full_unstemmed | Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title_short | Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
title_sort | barriers and facilitators associated with pharmacological treatment in bipolar disorder patients |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471582/ http://dx.doi.org/10.1192/j.eurpsy.2021.519 |
work_keys_str_mv | AT parterajaalcala barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT navasafontalba barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT moralesmcompany barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT guillenaslromero barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT higuerastgutierrez barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT cortesfcalera barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT foressvicent barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients AT rojaslgutierrez barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients |